November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and pharmaceutical industry executive, as the company’s CEO.
{iframe}https://biobuzz.io/todd-chappell-appointed-ceo-of-rasio-therapeutics/{/iframe}